{"url_path":"/sec/clro/8-k/2026-07-06/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/840715/0001753926-26-001137-index.html","accession_number":"0001753926-26-001137","cik":"0000840715","ticker":"CLRO","issuer_name":"CLEARONE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/840715/0001753926-26-001137-index.html","primary_entity_key":"0000840715","primary_entity_name":"CLEARONE INC"},"word_count":110,"has_tables":true,"body_markdown":"Item 9.01              Financial Statements and Exhibits\n\n(d)  Exhibits \n\nExhibit Number\n\n \n\nExhibit Title\n\n[2.1](ex21_1.htm)\n\n[Agreement and Plan of Merger, dated as of July\n1, 2026, by and among ClearOne, Inc., CLRO Merger Sub, Inc., Cortigent, Inc.,\nand Vivani Medical, Inc.](ex21_1.htm)\n\n[99.1](ex991_2.htm)\n\n[Press Release of ClearOne, Inc. dated July 2, 2026.](ex991_2.htm)\n\n104.1\n\n \n\nThe cover page from this Current Report on Form 8-K, formatted in Inline XBRL.\n\n **\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nCLEARONE, INC.\n\n \n\n \n\n \n\nDate:  July 6, 2026\n\nBy:\n\n/s/ Simon Brewer\n\n \n\n \n\nSimon Brewer\n\n \n\n \n\nChief Financial Officer"}